EyePoint Pharma - Bathi resik saben siji saham sajrone rolas wulan pungkasan EYPT

The success of EyePoint Pharmaceuticals (EYPT) relies on regulatory verdicts regarding new drugs, as clearly demonstrated by the annual percentage change in EPS TTM. Currently, -33.00 represents the latest level value. EyePoint Pharmaceuticals (EYPT) aims to replace painful injections for AMD with the Durasert system, establishing a robust patent barrier through its unique microcapsule technology for sustained drug release.

EYPT EyePoint Pharma: Bathi resik saben saham (EPS TTM) ing interval 11.02.2024 - 14.11.2026

EyePoint Pharma - rincian analitis lan metrik utama (EYPT)

- rega lan prakiraan konsensus rega:

Rega bursa eyepointpharma.com|EYPT - Prakiraan konsensus analis

- rincian nilai pasar emiten:

Nilai pasar EyePoint Pharmaceuticals Inc|EYPT - Nilai Total Perusahaan

- rincian nilai buku perusahaan:

Aset Bersih saben Saham EyePoint Pharmaceuticals|EYPT - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku eyepointpharma.com|EYPT - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal EyePoint Pharmaceuticals|EYPT - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal EyePoint Corp|EYPT - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku EyePoint Pharmaceuticals Inc|EYPT - Utang jangka dawa perusahaan|Utang jangka cendhak EyePoint Pharmaceuticals|Koefisien jangkoan perantara eyepointpharma.com

- data bathi bisnis lan rasio investasi:

EYPT - Bathi resik perusahaan|Prakiraan bathi resik EyePoint Pharmaceuticals|EYPT - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep EyePoint Pharmaceuticals Inc|EYPT - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan EyePoint Pharmaceuticals Inc|EYPT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan EyePoint Pharmaceuticals|EYPT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan eyepointpharma.com|EYPT - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep EyePoint Pharmaceuticals

- indikator dodolan lan pendapatan:

EYPT - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan eyepointpharma.com|EYPT - Rasio rega marang pendapatan|Multiplikator forward rega marang pendapatan EyePoint Pharmaceuticals Inc

Analisis wiwitan perusahaan:eyepointpharma.com

Barang utama EyePoint Pharmaceuticals, Inc.

This indicator captures the percentage change in net income per share over a rolling year, allowing investors to assess the actual profitability dynamics of the business. By analyzing the annual growth of EPS TTM, one can track the sensitivity of the market capitalization to the efficiency of the proprietary Durasert technology and the patent protection of new ophthalmological drugs, which determine the future financial results of EyePoint Pharmaceuticals (EYPT).

Analisis pesaing